BioStacks

Herb

Astragalus & Panax notoginseng Extract

Evidence

Limited
Evidence: 2 of 5 (Limited)

What the evidence says

A patented (NuLiv Science) blend of highly fractionated Astragalus membranaceus and Panax notoginseng root extracts, marketed to enhance intestinal absorption of amino acids, peptides, glucose, and vitamins by upregulating nutrient transporter expression.

Marketed absorption enhancer; supporting data is primarily in-vitro and animal studies funded by the manufacturer (NuLiv Science), with no independent human RCTs

Top Astragalus & Panax notoginseng Extract supplements

About Astragalus & Panax notoginseng Extract

A patented (NuLiv Science) blend of highly fractionated Astragalus membranaceus and Panax notoginseng root extracts, marketed to enhance intestinal absorption of amino acids, peptides, glucose, and vitamins by upregulating nutrient transporter expression. The supporting evidence is almost entirely in-vitro (Caco-2 cell models) and animal studies, the majority conducted or funded by the manufacturer; there are no independent human RCTs demonstrating improved nutrient absorption or any clinical outcome in people. Per our evidence hierarchy this is mechanistic-tier data and should not be used for clinical efficacy claims. Distinct from the standalone Astragalus Root entry, which is dosed and studied as a herb in its own right.

What Astragalus & Panax notoginseng Extract supports

  • Marketed to support nutrient absorption (mechanistic data only)

How much Astragalus & Panax notoginseng Extract to take

The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.

Effective

2550

mg

Proprietary absorption enhancer; commercial products dose 25–50 mg/day. Not a therapeutic dose range — there is no clinically validated effective dose in humans.

Clinical evidence

Limited clinical evidence. Marketed absorption enhancer; supporting data is primarily in-vitro and animal studies funded by the manufacturer (NuLiv Science), with no independent human RCTs

Examine.com